Cancer Research UK

EU flag
#ABPI #Cancer Research UK #EU #Horizon Europe #Life sciences #UK government

UK joins Horizon Europe in “huge win” for research community

Following lengthy negotiations, the UK government has announced that the UK will be participating as a fully associated member of Horizon Europe for the remaining life of the programme to 2027. UK researchers can now apply for grants and bid to take part in projects under… Read More

#News #Trending News

Telomeres on chromosomes
#Cancer research #Cancer Research UK #Institute of Cancer Research #Oncology

Study identifies potential new cancer drug targets

A new study has provided insights into the biological mechanism that supports survival of hard-to-treat cancers. In the new study, led by scientists at The Institute of Cancer Research and published in Nature Communications, researchers identify a new cellular role of a protein called EXD2 nuclease… Read More

#Cancer Research #News

Tumour microenvironment
#Cancer research #Cancer Research UK #Immunotherapy #Oncology #Phase I trial #Solid tumours #Sosei Heptares

Immunotherapy for solid tumours progresses to human trials

Research partners in the UK are progressing their orally available small molecule cancer immunotherapy drug into clinical development as a treatment for advanced solid tumours. Sosei Group and Cancer Research UK announced that the first patient has been dosed in a Phase I/IIa clinical trial evaluating… Read More

#Cancer Research #News

CAR-T therapy
#Aleta Biotherapeutics #Biologics #Cancer research #Cancer Research UK #CAR-T #MHRA #Oncology

Biologic CAR-T cell engager approved for UK clinical trial

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Aleta Biotherapeutics a clinical trial authorisation (CTA) to evaluate biologic ALETA-001 in a Phase I/II clinical trial in patients with B-cell malignancies who are relapsed/refractory to CD19 CAR-T cell therapy. The company’s collaboration partner, Cancer Research UK’s Centre for… Read More

#Cancer Research #News #Regulatory

T cells attacking cancer
#allogeneic cell therapies #Cancer research #Cancer Research UK #Lineage Cell Therapeutics #Lung cancer #Oncology

Topline results support allogeneic dendritic cell vaccine in lung cancer

Lineage Cell Therapeutics and Cancer Research UK have announced encouraging primary and secondary endpoint results from their clinical study of VAC2 in advanced non-small cell lung cancer (NSCLC). Five of eight patients treated (62.5%) had a best response of immune-related stable disease, and three (37.5%) demonstrated… Read More

#Cancer Research #News

IgE antibodies
#Antibody #Cancer research #Cancer Research UK #Epsilogen #King's College London #Oncology #Phase I trial

New class of antibody cancer drug shows promise

A Cancer Research UK-funded clinical trial has shown, for the first time, that a new class of antibody could benefit cancer patients whose existing treatments have stopped working. The Phase I clinical trial, sponsored and managed by Cancer Research UK’s Centre for Drug Development, tested whether… Read More

#Cancer Research #News

Cancer research lab
#Cancer research #Cancer Research UK #Clinical trial design #Oncology #Precision medicine

Cancer Research UK joins precision cancer medicine consortium

Cancer Research UK has joined the PRIME-ROSE project, a Europe-wide effort to boost patient access to precision cancer medicine (PCM). The PRIME-ROSE consortium consists of 24 partners, including nine beneficiaries and fifteen associated partners who will come together over the course of five years and work… Read More

#Cancer Research #News

Cancer Research UK Beatson Institute
#Animal models #Cancer research #Cancer Research UK #Cancer Research UK Beatson Institute #ELRIG #Events #Human disease models #Scotland #University of Glasgow

Scottish drug discovery: Advancing new research models

Following the Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provides a snapshot of drug discovery in Scotland. With over 150 pharma services/supply companies and 19 universities, Scotland is one of the most advanced life science sectors in the UK and the world. To demonstrate how Scotland is… Read More

#Exclusive Content

Antibodies attack cancer cell
#Antibodies #Cancer research #Cancer Research UK #Collaboration #Oncology #Partnership #UCB

CRUK and UCB advance oncology antibody candidates

Cancer Research UK and UCB have agreed a clinical development collaboration to advance two of UCB’s investigational oncology antibody candidates through clinical trials. The collaboration focuses on the development of two investigational antibody candidates, UCB6114 and UCB4594, by bringing together the oncology-focused translational research and clinical… Read More

#Cancer Research #News

Scientist in laboratory
#Cancer research #Cancer Research UK #Clinical trial #Genetic profiling #Rare cancers

Precision medicine study could find new options for rare cancers

Cancer Research UK, The University of Manchester and Roche have opened a multi-drug, precision medicine trial for people with rare cancers.  The trial is set up to recruit both paediatric and adult patients with any rare cancer type and is one of very few precision medicine platform… Read More

#Cancer Research #News

Cancer research lab
#Academic #Cancer #Cancer research #Cancer Research Horizons #Cancer Research UK #Collaboration #Oncology

Academic-industry collaboration extends cancer drug alliance 

Cancer Research UK’s innovation engine, Cancer Research Horizons, and Newcastle University, have agreed an extension of their strategic drug discovery alliance with Astex Pharmaceuticals.  The alliance will continue to focus on the discovery of potential new cancer drugs with associated biomarkers, with the aim of providing an… Read More

#Cancer Research #News

Rishi Sunak presenting the UK budget
#Academy of Medical Sciences #BioIndustry Association #Biomedical research #Cancer Research UK #Economy #Funding #Investment #UK budget #UK economy #UK government

UK biomedical organisations warn against research cuts 

Ahead of the UK Government’s Autumn Statement on Thursday, leading biomedical research companies, charities and institutions have called for the Chancellor to place medical and health research at the heart of plans for growth.  The letter has been signed by the Academy of Medical Sciences, Pfizer, Wellcome,… Read More

#News

Stomach cancer cells
#ATR inhibitors #Cancer #Cancer research #Cancer Research UK #CRISPR #Drug resistance #Gene editing #Genetic study #Stomach cancer #The Institute of Cancer Research

Study reveals how stomach cancers develop drug resistance

Scientists have shown how stomach cancers can develop resistance to a new class of drugs called ATR inhibitors by switching off the activity of two key genes – raising the possibility of outsmarting cancer by predicting drug resistance in advance.  The findings could pave the way for… Read More

#Cancer Research #News

#Cancer research #Cancer Research Horizons #Cancer Research UK #Drug development #Drug discovery #Oncology

New horizon for cancer innovation

Listen to this article on the DDW podcast: Earlier this year, Cancer Research UK (CRUK) launched its innovation engine, Cancer Research Horizons, to streamline drug discovery through the combination of its commercial and therapeutics teams. Reece Armstrong sits down with Cancer Research Horizons’ Chief Business Officer, Tony Hickson and CEO of… Read More

#Cancer Research #Exclusive Content

#Cancer Research UK #Oncology #Stichting Oncode Institute

Cancer Research UK & Oncode to boost international collaboration  

Cancer Research UK has formed a strategic alliance with a research institute in the Netherlands as part of a joint effort to boost understanding into cancer and to translate research in patient benefits.   Cancer Research UK will work with the Stichting Oncode Institute in the Netherlands on… Read More

#News